Sign in Subscribe
Charities

Mum's Brave Battle Against Aggressive Brain Tumour a Warning to Families Everywhere

Strategic Insights

— 1 min read

Charlotte Coxon was diagnosed with a glioblastoma, one of the most aggressive and cancerous types of brain tumours, after experiencing headaches while wrapping Christmas presents for her two children in late 2021. Despite undergoing surgery, chemotherapy, and radiotherapy, the tumour continued to spread, and Charlotte passed away on July 9 last year, leaving behind her husband, Jonny, and their two children, Thomas and Anna. The family has since dedicated themselves to supporting Brain Tumour Research in its mission to find a cure for the disease that took Charlotte from them.

Key Takeaways:

  • Charlotte Coxon, a 39-year-old mum of two, was diagnosed with a glioblastoma, a highly aggressive and cancerous type of brain tumour, after experiencing headaches in late 2021.
  • Despite undergoing surgery, chemotherapy, and radiotherapy, the tumour continued to spread, and Charlotte passed away on July 9, 2022.
  • Charlotte's husband, Jonny, has stated that she was an "incredibly family-oriented person" who always prioritized her children, Thomas, 7, and Anna, 4.
  • The tumour returned in March 2022, after a routine check-up with Charlotte's oncologist, leading to a rapid decline in her health.
  • Charlotte worked hard to prepare her children for her impending death and received support from several charities, including the Laura Centre in Leicester.
  • The Coxon family is now dedicated to supporting Brain Tumour Research, raising awareness, and funds for the organization.

Statistics:

  • 1 in 1,000 people in the UK will develop a brain tumour each year (Source: Brain Tumour Research).
  • Just 1% of the national cancer research budget is allocated to brain tumours, making breakthroughs and cures less likely (Source: Ashley McWilliams, Brain Tumour Research).
  • Glioblastoma is one of the most aggressive and cancerous types of brain tumours, with a 5-year survival rate of 5-10% (Source: Cancer Research UK).

Sources:

  • Brain Tumour Research
  • Ashley McWilliams, community development manager at Brain Tumour Research
  • Cancer Research UK

Read more